Skip to main content
. Author manuscript; available in PMC: 2010 May 18.
Published in final edited form as: BJU Int. 2008 Apr 10;102(6):736–740. doi: 10.1111/j.1464-410X.2008.07631.x

FIG. 1.

FIG. 1

Comparison of the basal ICP at 1 week after intracorporal injection with 100 μg plasmids expressing hSlo, SMR3A, SMR3B, ProL1 or Vcsa1 with control (rats injected with the parent vector, pVAX). *P < 0.05 vs pVAX control.